Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-01-19
1997-07-01
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514338, 514341, 514366, 514376, 514377, 514407, 546146, 546147, 546162, 546174, 546175, 548162, 548222, 5483111, 5483697, A61K 3147, A61K 31415, C07D23118, C07D23354
Patent
active
056439261
ABSTRACT:
Novel substituted pyrazolidinones have been found to exhibit significant binding to cholecystokinin (CCK) receptors and gastrin receptors in the brain and/or peripheral sites such as the pancreas, stomach, and ileum. The pyrazolidinones are CCK and gastrin receptor antagonists and find therapeutic application in the treatment of gastrointestinal disorders, central nervous system disorders and for appetite regulation in warm-blood vertebrates. Pharmaceutical formulations for such indications are described.
REFERENCES:
patent: 3312550 (1967-04-01), Stewart et al.
patent: 3433634 (1969-03-01), De Haes
patent: 3674480 (1972-07-01), Kempfer et al.
patent: 3740221 (1973-06-01), Willems et al.
patent: 3957814 (1976-05-01), Moller et al.
patent: 4081596 (1978-03-01), Moller et al.
patent: 4220710 (1980-09-01), Janssens et al.
patent: 4340662 (1982-07-01), Ovshinsky et al.
patent: 4902708 (1990-02-01), Kim
patent: 5300514 (1994-04-01), Brown et al.
Neitzel et al., Liebigs Ann. Chem., 1907-1912 (1980).
Howbert et al., Multiple Cholecystokinin Receptors--Progress Toward CNS Therapeutic Targets Abstract, Harlow, England, Sep. 20-22, 1990.
Hodgkiss, et al. Multiple Cholecystokinin Receptors--Progress Toward CNS Therapeutic Targets Abstract, Harlow, England, Sep. 20-22, 1990.
Lucaites et al., Soc. Neurosci. Abstr. 16:82, 1990.
Howbert et al., Soc. Neurosci. Abstr. 16:82, 1990.
Howbert, Joint Great Lakes-Central Regional Meeting of American Chemical Society, Indianapolis, In, May 29-31, 1991.
Howbert, Invited Lectures, McGill University (Nov. 28, 1990; Dec. 6, 1990), Univ. Sherbrook (Nov. 29, 1990), Indiana Univ. School of Med. (Dec. 4, 1990), Johns Hopkins Univ. (Jan. 29, 1991) Howbert, Society for Drug Research, London, England, Mar. 21, 1991.
Chemical Abstract vol. 67 No. 90805, Kaupman et al, Mar. 16, 1967 "4-Phenyl 5 propyl-3 pyrazolidone, effective as a hypnotic and a sedative".
Brown Raymond F.
Greenwood Beverley
Howbert J. Jeffry
Lobb Karen L.
Neel David A.
Covington Raymond
Eli Lilly and Company
Ivy C. Warren
Vorndran-Jones MaCharri
LandOfFree
Pyrazolidinone CCK and gastrin antagonists and pharmaceutical fo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolidinone CCK and gastrin antagonists and pharmaceutical fo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolidinone CCK and gastrin antagonists and pharmaceutical fo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597492